CYTK7:30 AMCytokinetics Announces Call for Proposals for Ninth Annual Communications Grant Programcytokinetics.com
CYTK4:00 PMCytokinetics Reports Second Quarter 2026 Financial Results and Provides Business Updatecytokinetics.com
CYTK6:20 AMCytokinetics Announces MHRA Marketing Authorisation for MYQORZO®▼ (aficamten) and Positive Guidance from NICE for Symptomatic Obstructive Hypertrophic Cardiomyopathy in England and Walescytokinetics.com
CYTK4:00 PMCytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)cytokinetics.com